In thyroid cancers, hsa_circ_0062389 (circ0062389) competitively binds to miR-1179, resulting in upregulation of HMGB1 expression, inhibition of E-cadherin protein expression, and enhancing TC metastasis [46]. Here, HMGB1 is linked to thyroid gland carcinoma.